Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies

Internal and Emergency Medicine

Volumn 9, Issue 3, 2014, Pages 267-272

  Camous, Laurent ^a,b   Veyradier, Agnès ^c,d   Darmon, Michael ^a,b   Galicier, Lionel ^a,b   Mariotte, Eric ^a,b   Canet, Emmanuel ^a,b   Parquet, Nathalie ^a,b   Azoulay, Élie ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b University   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d Dept Environ Med Natl Inst Publ HIth   (Norway)

Author keywords

Acute respiratory failure; Phlebitis; Stroke; Thrombotic thrombocytopenic purpura

Indexed keywords

ADULT; AGED; COMPLICATION; CRITICAL ILLNESS; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; YOUNG ADULT;

ADULT; AGED; CRITICAL ILLNESS; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; THROMBOTIC MICROANGIOPATHIES; YOUNG ADULT;

EID: 84897022786     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-012-0851-4     Document Type: Article

References (19)

1. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347(8): 589-600.
2. Dragon-Durey MA, Fremeaux-Bacchi V (2005) Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 27(3): 359-374.
3. Patschan D et al (2006) Acute myocardial infarction in thrombotic microangiopathies-clinical characteristics, risk factors and outcome. Nephrol Dial Transpl 21(6): 1549-1554.
4. Hosler GA, Cusumano AM, Hutchins GM (2003) Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med 127(7): 834-839.
5. Yarranton H et al (2003) Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 121(5): 778-785.
6. Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med 359(9): 938-949.
7. Ferrari S et al (2007) Prognostic value of anti-ADAMTS13 antibodies feature (Ig isotype titer and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with an undetectable ADAMTS13 activity. Blood 109(7): 2815-2822.
8. Lara PN Jr et al (1999) Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med 107(6): 573-579.
9. Rizvi MA et al (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion 40(8): 896-901.
10. Flamholz R et al (2000) Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses? J Clin Apher 15(3): 169-172.
11. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH (2001) Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161(10): 1268-1279.
12. Hawkins BM et al (2008) Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion 48(2): 382-392.
13. Joannidis M et al (2009) Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 35(10): 1692-1702.
14. Meloni G et al (2001) Thrombotic thrombocytopenic purpura: prospective neurologic, neuroimaging and neurophysiologic evaluation. Haematologica 86(11): 1194-1199.
15. Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165(6): 710-718.
16. Franchini M, Lippi G (2006) Von Willebrand factor and thrombosis. Ann Hematol 85(7): 415-423.
17. Tostivint I et al (2002) Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade. Nephrol Dial Transpl 17(7): 1228-1234.
18. Terrell DR et al (2005) The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 3(7): 1432-1436.
19. Sucker C et al (2009) The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies. Clin Appl Thromb Hemost 15(3): 360-363.